November 3, 2022 Single-molecule array assay reveals the prognostic impact of plasma LRIG1 in ovarian carcinoma
October 17, 2022 Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
August 11, 2022 Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
August 2, 2022 Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic
May 15, 2022 Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
May 14, 2022 Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217
April 23, 2022 Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
April 5, 2022 Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer’s continuum